Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moreau

Showing results (481-490 of 570) with videos related to

Pageof 57
Sort By:
Leukemia|July 18, 2013
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myelomaC Touzeau, C Dousset, S Le Gouill, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2000
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapyM a Mahé, S Bourdin, A Le Pourhiet-Le Mevel, et al.
Leukemia|February 3, 2007
Rituximab in CD20 positive multiple myelomaP Moreau, L Voillat, L Benboukher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myelomaP Moreau, D Fiere, W R Bezwoda, et al.
The Review of Scientific Instruments|November 8, 2018
Steady state magnetic sensors for ITER and beyond: Development and final design (invited)M Kocan, I Duran, S Entler, et al.
Bone Marrow Transplantation|April 4, 2017
Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrierA Garnier, T Guillaume, P Peterlin, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2015
Chemotherapy-driven dysbiosis in the intestinal microbiomeE Montassier, T Gastinne, P Vangay, et al.
AIDS Research and Human Retroviruses|July 1, 1996
Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 regionD Londos-Gagliardi, R Dalibart, S Geoffre, et al.
Biochemistry|January 23, 1990
Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cellsL H Wang, D H Coy, J E Taylor, et al.
Bone Marrow Transplantation|November 29, 2011
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicityT Guillaume, B Gaugler, P Chevallier, et al.
Pageof 57

Showing results (481-490 of 570) with videos related to

Sort By:
Pageof 57
Leukemia|July 18, 2013
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myelomaC Touzeau, C Dousset, S Le Gouill, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2000
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapyM a Mahé, S Bourdin, A Le Pourhiet-Le Mevel, et al.
Leukemia|February 3, 2007
Rituximab in CD20 positive multiple myelomaP Moreau, L Voillat, L Benboukher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myelomaP Moreau, D Fiere, W R Bezwoda, et al.
The Review of Scientific Instruments|November 8, 2018
Steady state magnetic sensors for ITER and beyond: Development and final design (invited)M Kocan, I Duran, S Entler, et al.
Bone Marrow Transplantation|April 4, 2017
Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrierA Garnier, T Guillaume, P Peterlin, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2015
Chemotherapy-driven dysbiosis in the intestinal microbiomeE Montassier, T Gastinne, P Vangay, et al.
AIDS Research and Human Retroviruses|July 1, 1996
Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 regionD Londos-Gagliardi, R Dalibart, S Geoffre, et al.
Biochemistry|January 23, 1990
Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cellsL H Wang, D H Coy, J E Taylor, et al.
Bone Marrow Transplantation|November 29, 2011
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicityT Guillaume, B Gaugler, P Chevallier, et al.
Pageof 57